Home
About
Overview
Sharing Data
ORCID
Help
History (19)
V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin.
The 1200 Patients Project: Studying Clinical Implementation of Pharmacogenomics
beta-MSH
Priming of naive T cells inside tumors leads to eradication of established tumors.
Non-viral precision T?cell receptor replacement for personalized cell therapy.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Non-viral precision T?cell receptor replacement for personalized cell therapy.
Non-viral precision T?cell receptor replacement for personalized cell therapy. Nature. 2023 03; 615(7953):687-696.
View in:
PubMed
subject areas
Antigens, Neoplasm
Biopsy
Cell- and Tissue-Based Therapy
CRISPR-Cas Systems
Disease Progression
Encephalitis
Gene Editing
Gene Knock-In Techniques
Gene Knockout Techniques
Genes, T-Cell Receptor alpha
Genes, T-Cell Receptor beta
HLA Antigens
Humans
Mutation
Neoplasms
Patient Safety
Precision Medicine
Receptors, Antigen, T-Cell
T-Lymphocytes
Transgenes
authors with profiles
Olivier G. Dalmas